Structure-based mutagenesis identifies important novel determinants of the NS2B cofactor of the West Nile virus two-component NS2B–NS3 proteinase

References

1. Aleshin A. E., Shiryaev S. A., Strongin A. Y., Liddington R. C. 2007; Structural evidence for regulation and specificity of flaviviral proteases and evolution of the Flaviviridae fold. Protein Sci 16:795–806 [CrossRef]
   [Google Scholar]
2. Beasley D. W. 2005; Recent advances in the molecular biology of West Nile virus. Curr Mol Med 5:835–850 [CrossRef]
   [Google Scholar]
3. Bessaud M., Grard G., Peyrefitte C. N., Pastorino B., Rolland D., Charrel R. N., de Lamballerie X., Tolou H. J. 2005; Identification and enzymatic characterization of NS2B–NS3 protease of Alkhurma virus, a class-4 flavivirus. Virus Res 107:57–62 [CrossRef]
   [Google Scholar]
4. Cahour A., Falgout B., Lai C. J. 1992; Cleavage of the dengue virus polyprotein at the NS3/NS4A and NS4B/NS5 junctions is mediated by viral protease NS2B–NS3, whereas NS4A/NS4B may be processed by a cellular protease. J Virol 66:1535–1542
   [Google Scholar]
5. Chambers T. J., Nestorowicz A., Amberg S. M., Rice C. M. 1993; Mutagenesis of the yellow fever virus NS2B protein: effects on proteolytic processing, NS2B–NS3 complex formation, and viral replication. J Virol 67:6797–6807
   [Google Scholar]
6. Chambers T. J., Droll D. A., Tang Y., Liang Y., Ganesh V. K., Murthy K. H., Nickells M. 2005; Yellow fever virus NS2B–NS3 protease: characterization of charged-to-alanine mutant and revertant viruses and analysis of polyprotein-cleavage activities. J Gen Virol 86:1403–1413 [CrossRef]
   [Google Scholar]
7. Chappell K. J., Stoermer M. J., Fairlie D. P., Young P. R. 2006; Insights to substrate binding and processing by West Nile virus NS3 protease through combined modeling, protease mutagenesis, and kinetic studies. J Biol Chem 281:38448–38458 [CrossRef]
   [Google Scholar]
8. Chappell K. J., Stoermer M. J., Fairlie D. P., Young P. R. 2007; Generation and characterization of proteolytically active and highly stable truncated and full-length recombinant West Nile virus NS3. Protein Expr Purif 53:87–96 [CrossRef]
   [Google Scholar]
9. Droll D. A., Krishna Murthy H. M., Chambers T. J. 2000; Yellow fever virus NS2B–NS3 protease: charged-to-alanine mutagenesis and deletion analysis define regions important for protease complex formation and function. Virology 275:335–347 [CrossRef]
   [Google Scholar]
10. Erbel P., Schiering N., D'Arcy A., Renatus M., Kroemer M., Lim S. P., Yin Z., Keller T. H., Vasudevan S. G., Hommel U. 2006; Structural basis for the activation of flaviviral NS3 proteases from dengue and West Nile virus. Nat Struct Mol Biol 13:372–373 [CrossRef]
    [Google Scholar]
11. Falgout B., Pethel M., Zhang Y. M., Lai C. J. 1991; Both nonstructural proteins NS2B and NS3 are required for the proteolytic processing of dengue virus nonstructural proteins. J Virol 65:2467–2475
    [Google Scholar]
12. Falgout B., Miller R. H., Lai C. J. 1993; Deletion analysis of dengue virus type 4 nonstructural protein NS2B: identification of a domain required for NS2B–NS3 protease activity. J Virol 67:2034–2042
    [Google Scholar]
13. Knox J. E., Ma N. L., Yin Z., Patel S. J., Wang W. L., Chan W. L., Ranga Rao K. R., Wang G., Ngew X. other authors 2006; Peptide inhibitors of West Nile NS3 protease: SAR study of tetrapeptide aldehyde inhibitors. J Med Chem 49:6585–6590 [CrossRef]
    [Google Scholar]
14. Leung D., Schroder K., White H., Fang N. X., Stoermer M. J., Abbenante G., Martin J. L., Young P. R., Fairlie D. P. 2001; Activity of recombinant dengue 2 virus NS3 protease in the presence of a truncated NS2B co-factor, small peptide substrates, and inhibitors. J Biol Chem 276:45762–45771 [CrossRef]
    [Google Scholar]
15. Lin C., Amberg S. M., Chambers T. J., Rice C. M. 1993; Cleavage at a novel site in the NS4A region by the yellow fever virus NS2B–3 proteinase is a prerequisite for processing at the downstream 4A/4B signalase site. J Virol 67:2327–2335
    [Google Scholar]
16. Lin C. W., Huang H. D., Shiu S. Y., Chen W. J., Tsai M. H., Huang S. H., Wan L., Lin Y. J. 2007; Functional determinants of NS2B for activation of Japanese encephalitis virus NS3 protease. Virus Res 127:88–94 [CrossRef]
    [Google Scholar]
17. Lohr K., Knox J. E., Phong W. Y., Ma N. L., Yin Z., Sampath A., Patel S. J., Wang W. L., Chan W. L. other authors 2007; Yellow fever virus NS3 protease: peptide-inhibition studies. J Gen Virol 88:2223–2227 [CrossRef]
    [Google Scholar]
18. Madden K. 2003; West Nile virus infection and its neurological manifestations. Clin Med Res 1:145–150 [CrossRef]
    [Google Scholar]
19. Mukhopadhyay S., Kuhn R. J., Rossmann M. G. 2005; A structural perspective of the flavivirus life cycle. Nat Rev Microbiol 3:13–22 [CrossRef]
    [Google Scholar]
20. Nall T. A., Chappell K. J., Stoermer M. J., Fang N. X., Tyndall J. D., Young P. R., Fairlie D. P. 2004; Enzymatic characterization and homology model of a catalytically active recombinant West Nile virus NS3 protease. J Biol Chem 279:48535–48542 [CrossRef]
    [Google Scholar]
21. Niyomrattanakit P., Winoyanuwattikun P., Chanprapaph S., Angsuthanasombat C., Panyim S., Katzenmeier G. 2004; Identification of residues in the dengue virus type 2 NS2B cofactor that are critical for NS3 protease activation. J Virol 78:13708–13716 [CrossRef]
    [Google Scholar]
22. Pastorino B. A., Peyrefitte C. N., Grandadam M., Thill M. C., Tolou H. J., Bessaud M. 2006; Mutagenesis analysis of the NS2B determinants of the Alkhurma virus NS2B–NS3 protease activation. J Gen Virol 87:3279–3283 [CrossRef]
    [Google Scholar]
23. Preugschat F., Strauss J. H. 1991; Processing of nonstructural proteins NS4A and NS4B of dengue 2 virus in vitro and in vivo . Virology 185:689–697 [CrossRef]
    [Google Scholar]
24. Shiryaev S. A., Ratnikov B. I., Chekanov A. V., Sikora S., Rozanov D. V., Godzik A., Wang J., Smith J. W., Huang Z. other authors 2006; Cleavage targets and the d-arginine-based inhibitors of the West Nile virus NS3 processing proteinase. Biochem J 393:503–511 [CrossRef]
    [Google Scholar]
25. Shiryaev S. A., Aleshin A. E., Ratnikov B. I., Smith J. W., Liddington R. C., Strongin A. Y. 2007; Expression and purification of a two-component flaviviral proteinase resistant to autocleavage at the NS2B–NS3 junction region. Protein Expr Purif 52:334–339 [CrossRef]
    [Google Scholar]
26. van der Meulen K. M., Pensaert M. B., Nauwynck H. J. 2005; West Nile virus in the vertebrate world. Arch Virol 150:637–657 [CrossRef]
    [Google Scholar]
27. Wang T., Town T., Alexopoulou L., Anderson J. F., Fikrig E., Flavell R. A. 2004; Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis. Nat Med 10:1366–1373 [CrossRef]
    [Google Scholar]
28. Wu C. F., Wang S. H., Sun C. M., Hu S. T., Syu W. J. 2003; Activation of dengue protease autocleavage at the NS2B–NS3 junction by recombinant NS3 and GST-NS2B fusion proteins. J Virol Methods 114:45–54 [CrossRef]
    [Google Scholar]
29. Yin Z., Patel S. J., Wang W. L., Chan W. L., Ranga Rao K. R., Wang G., Ngew X., Patel V., Beer D. other authors 2006; Peptide inhibitors of dengue virus NS3 protease. Part 2: SAR study of tetrapeptide aldehyde inhibitors. Bioorg Med Chem Lett 16:40–43 [CrossRef]
    [Google Scholar]